Glen­mark gets two ANDA ap­provals from USFDA

The Financial Express - - COMPANIES -

Glen­mark Phar­ma­ceu­ti­cals has re­ceived fi­nal ap­proval from the US health reg­u­la­tor USFDA for oral con­tra­cep­tives and leukemia treat­ment in­jec­tion. “Glen­mark Phar­ma­ceu­ti­cals Inc, USA has been granted fi­nal ap­proval by the US Food and Drug Ad­min­is­tra­tion (USFDA) for drospirenone and ethinyl estra­diol... and for lev­onorgestrel tablets,” it said in a BSE fil­ing. Drospirenone and ethinyl estra­diol are generic ver­sion of Bayer Health­care's Yas­min tablets and lev­onorgestrel tablets is generic ver­sion of Teva Branded Phar­ma­ceu­ti­cal Prod­ucts' Plan B one-Step tablets.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.